Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

US8629148B2 · kind B2 · utility

Assignee

• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Wilfried Braje · Ludwigshafen, DE
• Astrid Netz · Mannheim, DE
• Thorsten Oost · Biberach an der Riß, DE
• Wolfgang Wernet · Ludwigshafen, DE
• Liliane Unger · Ludwigshafen, DE
• Wilfried Hornberger · Wiesbaden, DE
• Wilfried Lubisch · Mannheim, DE

Key dates

• Filing date: Dec 23, 2008
• Grant date: Jan 14, 2014
• Expiry date: Jun 24, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel substituted oxindole derivatives of the formula (I), pharmaceutical agents containing said derivatives, and the use thereof for the treatment of vasopressin-dependent illnesses.